Moufid Fatima Zahra, Bouguenouch Laila, El Bouchikhi Ihssane, Houssaini Mohamed Iraqui, Ouldim Karim
Department of Medical Genetics and Oncogenetics, Centre Hospitalier Universitaire Hassan II, Fez, Morocco; Microbial Biotechnology Laboratory, Faculté des Sciences et Techniques (FST), Université Sidi Mohammed Ben Abdellah (USMBA), Fez, Morocco.
Department of Medical Genetics and Oncogenetics, Centre Hospitalier Universitaire Hassan II, Fez, Morocco; Laboratory of Biomedical and Translational Research, Faculté de Médecine et de Pharmacie de Fès (FMPF), Université Sidi Mohammed Ben Abdellah (USMBA), Fez, Morocco.
Turk J Gastroenterol. 2018 Nov;29(6):701-704. doi: 10.5152/tjg.2018.17761.
Lynch syndrome (LS) is an autosomal dominant disorder characterized by an increased risk of extracolonic cancers and early age of onset. It is associated with germline mutations in the DNA mismatch repair (MMR) genes. We report a case of a patient with colorectal cancer referred to our medical genetics department for molecular analysis and genetic counseling. The proband is a 64-year-old woman diagnosed with a tumor of the cecum. Histopathological examination showed a moderately differentiated mucinous adenocarcinoma categorized by pT3 N0. Analysis of her pedigree revealed three siblings who had colon cancer, as well as one relative with brain cancer. Based on these findings, molecular genetic investigation was found to be necessary in order to identify the disease-causing mutation. Immunohistochemistry staining of MMR proteins was performed on the tumor sample of the index proband. Mutational analysis of the MLH1/MSH2 genes was carried out. Analysis was extended to the family members and the general population. This led to the identification of a heterozygous frameshift duplication in the MLH1 gene at position 910 (c.910dupG). Three siblings had inherited the mutation from their mother, two of whom were asymptomatic at the time of diagnosis. To the best of our knowledge, this is a novel pathogenic duplication that has not been reported in the databases and literature. The outcome of the present case suggests that this mutation was the primary cause of LS in the family.
林奇综合征(LS)是一种常染色体显性疾病,其特征是患结外癌症的风险增加且发病年龄较早。它与DNA错配修复(MMR)基因的种系突变有关。我们报告了一例因分子分析和遗传咨询转诊至我们医学遗传学部门的结直肠癌患者。先证者是一名64岁女性,被诊断患有盲肠肿瘤。组织病理学检查显示为中度分化的黏液腺癌,分类为pT3 N0。对其家系的分析发现有三名患结肠癌的兄弟姐妹,以及一名患脑癌的亲属。基于这些发现,发现有必要进行分子遗传学研究以确定致病突变。对索引先证者的肿瘤样本进行了MMR蛋白的免疫组织化学染色。对MLH1/MSH2基因进行了突变分析。分析扩展到家庭成员和普通人群。这导致在MLH1基因第910位(c.910dupG)鉴定出一个杂合移码重复。三名兄弟姐妹从他们的母亲那里遗传了该突变,其中两人在诊断时无症状。据我们所知,这是一个尚未在数据库和文献中报道的新型致病重复。本病例的结果表明,该突变是该家族中LS的主要原因。